AAAAAA

   
Results: 1-17 |
Results: 17
NEUROCOGNITIVE DEFICITS, SYMPTOMS, NEUROLEPTIC SIDE-EFFECTS AND QUALITY-OF-LIFE IN SCHIZOPHRENIA
Authors: AWAD AG HESLEGRAVE RJ VORUGANTI LNP
Citation: Ag. Awad et al., NEUROCOGNITIVE DEFICITS, SYMPTOMS, NEUROLEPTIC SIDE-EFFECTS AND QUALITY-OF-LIFE IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 176-176
RE - CORRELATION BETWEEN COGNITIVE-FUNCTIONING AND THE SYMPTOMATOLOGYOF SCHIZOPHRENIA - THE AUTHORS RESPOND
Authors: VORUGANTI LNP HESLEGRAVE R AWAD AG
Citation: Lnp. Voruganti et al., RE - CORRELATION BETWEEN COGNITIVE-FUNCTIONING AND THE SYMPTOMATOLOGYOF SCHIZOPHRENIA - THE AUTHORS RESPOND, Canadian journal of psychiatry, 43(8), 1998, pp. 854-855
THE INFLUENCE OF NEUROCOGNITIVE DEFICITS AND SYMPTOMS ON QUALITY-OF-LIFE IN SCHIZOPHRENIA
Authors: HESLEGRAVE RJ AWAD AG VORUGANTI LNP
Citation: Rj. Heslegrave et al., THE INFLUENCE OF NEUROCOGNITIVE DEFICITS AND SYMPTOMS ON QUALITY-OF-LIFE IN SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 22(4), 1997, pp. 235-243
QUALITY-OF-LIFE MEASUREMENT DURING ANTIPSYCHOTIC DRUG-THERAPY OF SCHIZOPHRENIA
Authors: VORUGANTI LNP HESLEGRAVE RJ AWAD AG
Citation: Lnp. Voruganti et al., QUALITY-OF-LIFE MEASUREMENT DURING ANTIPSYCHOTIC DRUG-THERAPY OF SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 22(4), 1997, pp. 267-274
MEASURING QUALITY-OF-LIFE IN PATIENTS WITH SCHIZOPHRENIA
Authors: AWAD AG VORUGANTI LNP HESLEGRAVE RJ
Citation: Ag. Awad et al., MEASURING QUALITY-OF-LIFE IN PATIENTS WITH SCHIZOPHRENIA, PharmacoEconomics, 11(1), 1997, pp. 32-47
A CONCEPTUAL-MODEL OF QUALITY-OF-LIFE IN SCHIZOPHRENIA - DESCRIPTION AND PRELIMINARY CLINICAL VALIDATION
Authors: AWAD AG VORUGANTI LNP HESLEGRAVE RJ
Citation: Ag. Awad et al., A CONCEPTUAL-MODEL OF QUALITY-OF-LIFE IN SCHIZOPHRENIA - DESCRIPTION AND PRELIMINARY CLINICAL VALIDATION, Quality of life research, 6(1), 1997, pp. 21-26
NEUROCOGNITIVE DEFICITS AND NEUROLOGICAL SIGNS IN SCHIZOPHRENIA
Authors: WONG AHC VORUGANTI LNP HESLEGRAVE RJ AWAD AG
Citation: Ahc. Wong et al., NEUROCOGNITIVE DEFICITS AND NEUROLOGICAL SIGNS IN SCHIZOPHRENIA, Schizophrenia research, 23(2), 1997, pp. 139-146
NEUROCOGNITIVE CORRELATES OF POSITIVE AND NEGATIVE SYNDROMES IN SCHIZOPHRENIA
Authors: VORUGANTI LNP HESLEGRAVE RJ AWAD AG
Citation: Lnp. Voruganti et al., NEUROCOGNITIVE CORRELATES OF POSITIVE AND NEGATIVE SYNDROMES IN SCHIZOPHRENIA, Canadian journal of psychiatry, 42(10), 1997, pp. 1066-1071
NEUROLEPTIC DYSPHORIA MAY BE THE MISSING LINK BETWEEN SCHIZOPHRENIA AND SUBSTANCE-ABUSE
Authors: VORUGANTI LNP HESLEGRAVE RJ AWAD AG
Citation: Lnp. Voruganti et al., NEUROLEPTIC DYSPHORIA MAY BE THE MISSING LINK BETWEEN SCHIZOPHRENIA AND SUBSTANCE-ABUSE, The Journal of nervous and mental disease, 185(7), 1997, pp. 463-465
ASSESSMENT OF THE PATIENTS SUBJECTIVE EXPERIENCE IN ACUTE NEUROLEPTICTREATMENT - IMPLICATIONS FOR COMPLIANCE AND OUTCOME
Authors: AWAD AG VORUGANTI LNP HESLEGRAVE RJ HOGAN TP
Citation: Ag. Awad et al., ASSESSMENT OF THE PATIENTS SUBJECTIVE EXPERIENCE IN ACUTE NEUROLEPTICTREATMENT - IMPLICATIONS FOR COMPLIANCE AND OUTCOME, International clinical psychopharmacology, 11, 1996, pp. 55-59
THE AIMS OF ANTIPSYCHOTIC MEDICATION - WHAT ARE THEY AND ARE THEY BEING ACHIEVED
Authors: AWAD AG VORUGANTI LNP HESLEGRAVE RJ
Citation: Ag. Awad et al., THE AIMS OF ANTIPSYCHOTIC MEDICATION - WHAT ARE THEY AND ARE THEY BEING ACHIEVED, CNS DRUGS, 4(1), 1995, pp. 8-16
NEUROLOGICAL AND NEUROCOGNITIVE CORRELATES OF POSITIVE AND NEGATIVE SCHIZOPHRENIC SYNDROMES
Authors: VORUGANTI LNP HESLEGRAVE R AWAD AG
Citation: Lnp. Voruganti et al., NEUROLOGICAL AND NEUROCOGNITIVE CORRELATES OF POSITIVE AND NEGATIVE SCHIZOPHRENIC SYNDROMES, Schizophrenia research, 15(1-2), 1995, pp. 138-139
PRELIMINARY VALIDATION OF A CONCEPTUAL-MODEL TO ASSESS QUALITY-OF-LIFE IN SCHIZOPHRENIA
Authors: AWAD AG VORUGANTI LNP HESLEGRAVE R
Citation: Ag. Awad et al., PRELIMINARY VALIDATION OF A CONCEPTUAL-MODEL TO ASSESS QUALITY-OF-LIFE IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 213-213
NEUROPSYCHIATRIC CORRELATES OF QUALITY-OF-LIFE IN SCHIZOPHRENIA
Authors: HESLEGRAVE RJ VORUGANTI LNP AWAD AG
Citation: Rj. Heslegrave et al., NEUROPSYCHIATRIC CORRELATES OF QUALITY-OF-LIFE IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 216-217
PATIENTS SUBJECTIVE EXPERIENCES ON ANTIPSYCHOTIC MEDICATIONS - IMPLICATIONS FOR OUTCOME AND QUALITY-OF-LIFE
Authors: AWAD AG HOGAN TP VORUGANTI LNP HESLEGRAVE RJ
Citation: Ag. Awad et al., PATIENTS SUBJECTIVE EXPERIENCES ON ANTIPSYCHOTIC MEDICATIONS - IMPLICATIONS FOR OUTCOME AND QUALITY-OF-LIFE, International clinical psychopharmacology, 10, 1995, pp. 123-132
CLINICAL-EVALUATION OF PSYCHOTROPIC-DRUGS FOR PSYCHIATRIC-DISORDERS, PRINCIPLES AND PROPOSED GUIDELINES, VOL 2 - GROF,P
Authors: VORUGANTI LNP AWAD AG
Citation: Lnp. Voruganti et Ag. Awad, CLINICAL-EVALUATION OF PSYCHOTROPIC-DRUGS FOR PSYCHIATRIC-DISORDERS, PRINCIPLES AND PROPOSED GUIDELINES, VOL 2 - GROF,P, Journal of psychiatry & neuroscience, 19(2), 1994, pp. 152-152
AN EVALUATION OF COMPUTERIZED NEUROCOGNITIVE ASSESSMENT OF SCHIZOPHRENIA
Authors: HESLEGRAVE RH VORUGANTI LNP AWAD AG
Citation: Rh. Heslegrave et al., AN EVALUATION OF COMPUTERIZED NEUROCOGNITIVE ASSESSMENT OF SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 163-163
Risultati: 1-17 |